Despite the immense burden that symptoms of menopause create for women in mid-life, highly effective hormone therapy (HT) for menopausal symptoms is underutilized by the medical community. Recent publication of updated guidelines and position statements has led to an urgent need to educate clinicians about the role of HT in supporting symptomatic women through the transition of menopause and reducing the stigma around both the symptoms and their treatment. The COVID-19 pandemic has highlighted the value of telehealth, which is likely to outlast the pandemic. Many clinicians have limited training, experience, and confidence with this modality, creating a need for education on how best to provide postmenopausal care via telehealth.
This CME Outfitters BriefCase will utilize patient cases to illustrate how clinicians can optimize technology for the care of postmenopausal women, with special focus on current evidence-based guidance on the risks and benefits of HT and implementing best practices for telehealth consultations with postmenopausal patients.
At the end of this CME/CE activity, participants should be able to:
The following learning objectives pertain only to those requesting CNE or CPE credit:
Supported by an educational grant from Pfizer Inc.
OB/GYNs, urogynecologists, primary care physicians, PAs, nurse practitioners, and pharmacists
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Bachmann has no disclosures to report.
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
NOTE: Pharmacist CE Universal Activity Number, Enduring: JA0007185-0000-21-139-H01-P
Call us at 877.CME.PROS (877.263.7767).